NDC 0781-2043

Ribavirin

Ribavirin

Ribavirin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Sandoz Inc. The primary component is Ribavirin.

Product ID0781-2043_52ecf3bd-6c80-4361-804c-dac97bd735cb
NDC0781-2043
Product TypeHuman Prescription Drug
Proprietary NameRibavirin
Generic NameRibavirin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2004-04-06
Marketing CategoryANDA / ANDA
Application NumberANDA076192
Labeler NameSandoz Inc
Substance NameRIBAVIRIN
Active Ingredient Strength200 mg/1
Pharm ClassesNucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0781-2043-16

56 CAPSULE in 1 BOTTLE (0781-2043-16)
Marketing Start Date2004-04-06
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0781-2043-01 [00781204301]

Ribavirin CAPSULE
Marketing CategoryANDA
Application NumberANDA076192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-04-06
Marketing End Date2004-04-06

NDC 0781-2043-10 [00781204310]

Ribavirin CAPSULE
Marketing CategoryANDA
Application NumberANDA076192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-04-06
Marketing End Date2004-04-06

NDC 0781-2043-42 [00781204342]

Ribavirin CAPSULE
Marketing CategoryANDA
Application NumberANDA076192
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-04-06
Marketing End Date2018-07-31

NDC 0781-2043-67 [00781204367]

Ribavirin CAPSULE
Marketing CategoryANDA
Application NumberANDA076192
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-04-06
Marketing End Date2018-07-31

NDC 0781-2043-13 [00781204313]

Ribavirin CAPSULE
Marketing CategoryANDA
Application NumberANDA076192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-04-06
Marketing End Date2011-06-10

NDC 0781-2043-28 [00781204328]

Ribavirin CAPSULE
Marketing CategoryANDA
Application NumberANDA076192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-04-06
Marketing End Date2004-04-06

NDC 0781-2043-04 [00781204304]

Ribavirin CAPSULE
Marketing CategoryANDA
Application NumberANDA076192
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-04-06
Marketing End Date2018-07-31

NDC 0781-2043-16 [00781204316]

Ribavirin CAPSULE
Marketing CategoryANDA
Application NumberANDA076192
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-04-06
Marketing End Date2018-07-31

Drug Details

Active Ingredients

IngredientStrength
RIBAVIRIN200 mg/1

OpenFDA Data

SPL SET ID:dc637c8f-9669-4bc5-8787-1fd5abaa588e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 312817

    • Pharmacological Class

    • Nucleoside Analog [EXT]
    • Nucleoside Analog Antiviral [EPC]

    NDC Crossover Matching brand name "Ribavirin" or generic name "Ribavirin"

    NDCBrand NameGeneric Name
    0781-2043RibavirinRibavirin
    0781-5177RibavirinRibavirin
    42494-423RibavirinRibavirin
    53808-0781RibavirinRIBAVIRIN
    53808-0782RibavirinRIBAVIRIN
    54738-950ribavirinribavirin
    54738-951ribavirinribavirin
    54738-952ribavirinribavirin
    54738-953ribavirinribavirin
    63629-2149RibavirinRibavirin
    65841-046RibavirinRibavirin
    65841-129RibavirinRibavirin
    65841-260RibavirinRibavirin
    65841-603RibavirinRibavirin
    65841-632RibavirinRibavirin
    65862-207RibavirinRibavirin
    68084-179RibavirinRibavirin
    68382-046RibavirinRibavirin
    68382-260RibavirinRibavirin
    68382-129RibavirinRibavirin
    68382-128RibavirinRibavirin
    68382-395RIBAVIRINRIBAVIRIN
    68382-127RibavirinRibavirin
    68682-019RibavirinRibavirin
    65862-290RibavirinRibavirin
    68475-003RIBAVIRINRIBAVIRIN
    0074-3197ModeribaRibavirin
    0074-3282ModeribaRibavirin
    0085-1318REBETOLribavirin
    0187-0007VirazoleRibavirin
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.